Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Horwich

Showing results (61-70 of 84) with videos related to

Pageof 9
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2002
Extragonadal germ cell tumors of the mediastinum and retroperitoneum: results from an international analysisCarsten Bokemeyer, Craig R Nichols, Jean-P Droz, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|May 20, 2003
Extragonadal germ cell tumors: relation to testicular neoplasia and management optionsCarsten Bokemeyer, Jorg T Hartmann, Sophie D Fossa, et al.
International Journal of Radiation Oncology, Biology, Physics|June 8, 2017
Clinical Outcomes of Image Guided Adaptive Hypofractionated Weekly Radiation Therapy for Bladder Cancer in Patients Unsuitable for Radical TreatmentShaista Hafeez, Fiona McDonald, Susan Lalondrelle, et al.
Journal of the National Cancer Institute|February 8, 2007
Myocardial infarction mortality risk after treatment for Hodgkin disease: a collaborative British cohort studyAnthony J Swerdlow, Craig D Higgins, Paul Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 5, 2011
Second cancer risk after chemotherapy for Hodgkin's lymphoma: a collaborative British cohort studyAnthony J Swerdlow, Craig D Higgins, Paul Smith, et al.
The Lancet. Oncology|March 18, 2008
Intrinsic markers of tumour hypoxia and angiogenesis in localised prostate cancer and outcome of radical treatment: a retrospective analysis of two randomised radiotherapy trials and one surgical cohort studyRoy Vergis, Catherine M Corbishley, Andrew R Norman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2009
Randomized comparison of the stanford V regimen and ABVD in the treatment of advanced Hodgkin's Lymphoma: United Kingdom National Cancer Research Institute Lymphoma Group Study ISRCTN 64141244Peter J Hoskin, Lisa Lowry, Alan Horwich, et al.
International Journal of Radiation Oncology, Biology, Physics|March 31, 2016
Prospective Study Delivering Simultaneous Integrated High-dose Tumor Boost (≤70 Gy) With Image Guided Adaptive Radiation Therapy for Radical Treatment of Localized Muscle-Invasive Bladder CancerShaista Hafeez, Karole Warren-Oseni, Helen A McNair, et al.
Journal of the National Cancer Institute|August 21, 2014
Risk of premature menopause after treatment for Hodgkin's lymphomaAnthony J Swerdlow, Rosie Cooke, Andrew Bates, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 27, 2012
Breast cancer risk after supradiaphragmatic radiotherapy for Hodgkin's lymphoma in England and Wales: a National Cohort StudyAnthony J Swerdlow, Rosie Cooke, Andrew Bates, et al.
Pageof 9

Showing results (61-70 of 84) with videos related to

Sort By:
Pageof 9
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2002
Extragonadal germ cell tumors of the mediastinum and retroperitoneum: results from an international analysisCarsten Bokemeyer, Craig R Nichols, Jean-P Droz, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|May 20, 2003
Extragonadal germ cell tumors: relation to testicular neoplasia and management optionsCarsten Bokemeyer, Jorg T Hartmann, Sophie D Fossa, et al.
International Journal of Radiation Oncology, Biology, Physics|June 8, 2017
Clinical Outcomes of Image Guided Adaptive Hypofractionated Weekly Radiation Therapy for Bladder Cancer in Patients Unsuitable for Radical TreatmentShaista Hafeez, Fiona McDonald, Susan Lalondrelle, et al.
Journal of the National Cancer Institute|February 8, 2007
Myocardial infarction mortality risk after treatment for Hodgkin disease: a collaborative British cohort studyAnthony J Swerdlow, Craig D Higgins, Paul Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 5, 2011
Second cancer risk after chemotherapy for Hodgkin's lymphoma: a collaborative British cohort studyAnthony J Swerdlow, Craig D Higgins, Paul Smith, et al.
The Lancet. Oncology|March 18, 2008
Intrinsic markers of tumour hypoxia and angiogenesis in localised prostate cancer and outcome of radical treatment: a retrospective analysis of two randomised radiotherapy trials and one surgical cohort studyRoy Vergis, Catherine M Corbishley, Andrew R Norman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2009
Randomized comparison of the stanford V regimen and ABVD in the treatment of advanced Hodgkin's Lymphoma: United Kingdom National Cancer Research Institute Lymphoma Group Study ISRCTN 64141244Peter J Hoskin, Lisa Lowry, Alan Horwich, et al.
International Journal of Radiation Oncology, Biology, Physics|March 31, 2016
Prospective Study Delivering Simultaneous Integrated High-dose Tumor Boost (≤70 Gy) With Image Guided Adaptive Radiation Therapy for Radical Treatment of Localized Muscle-Invasive Bladder CancerShaista Hafeez, Karole Warren-Oseni, Helen A McNair, et al.
Journal of the National Cancer Institute|August 21, 2014
Risk of premature menopause after treatment for Hodgkin's lymphomaAnthony J Swerdlow, Rosie Cooke, Andrew Bates, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 27, 2012
Breast cancer risk after supradiaphragmatic radiotherapy for Hodgkin's lymphoma in England and Wales: a National Cohort StudyAnthony J Swerdlow, Rosie Cooke, Andrew Bates, et al.
Pageof 9